SCHEMBL27455092

SCHEMBL27455092

Cn1cc(-c2nc3c(-c4ccc(CNc5noc(C6CC6)n5)c(F)c4)ccnc3[nH]2)cn1

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BTK Q06187 20/20 0.49
▸ LCK P06239 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17645795 0.88 BTK (0.63) BTKLCK
SCHEMBL27449707 0.87 BTK (0.37) BTKLCK
SCHEMBL24061705 0.83 BTK (0.58) BTKLCK
SCHEMBL27455094 0.83 BTK (0.52) BTKLCK
SCHEMBL17660312 0.82 BTK (0.57) BTKLCK
SCHEMBL30950536 0.81 BTK (0.47) BTKLCK
SCHEMBL27460920 0.81 BTK (0.47) BTKLCK
SCHEMBL17645888 0.81 BTK (0.73) BTKLCK
SCHEMBL30950575 0.81 BTK (0.59) BTKLCK
SCHEMBL17645701 0.81 BTK (0.59) BTKLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024129395-A1 BTK INHIBITORS GWYNANT THERAPEUTICS, INC. (US) 2024-06-20 — — WO disclosed
WO-2024129395-A1 BTK INHIBITORS GWYNANT THERAPEUTICS, INC. (US) 2024-06-20 — — WO disclosed
Send feedback